Fig. 3From: Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trialiDFS in Kaplan–Meier analysis for 3-week measurements, i.e., 3wTIL+ versus 3wTIL− versus 3wLC (low cellularity), in A all patients, B patients with non-pCR and C patients with pCR and D iDFS in Kaplan–Meier analysis for subgroups defined (see text) by sTIL transitions from baseline to 3 weeksBack to article page